Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Skin Neoplasms 1

Interventions

pembrolizumab 2Standard of Care 2Methods 2Interviews as Topic 2Educational Status 2Early Intervention, Educational 2Counseling 2Blood Specimen Collection 2zilucoplan 1sacituzumab govitecan 1rozanolixizumab 1oxycodone-acetaminophen 1ibrutinib 1erdafitinib 1enzalutamide 1enfortumab vedotin 1dynorphin-converting endopeptidase 1durvalumab 1brexucabtagene autoleucel 1axicabtagene ciloleucel 1avelumab 1Vinblastine 1Tramadol 1Surgical Procedures, Operative 1Stents 1Specimen Handling 1Semen Analysis 1Robotic Surgical Procedures 1Protons 1Pregabalin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × oxycodone-acetaminophen × 30 days × Clear all
NCT07575230 2026-05-11

Suzetrigine vs Norco-postoperative Mohs Pain

Baylor Research Institute

Phase 4 Enrolling by invitation
75 enrolled
Dermatologic

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡